Opinion: What leaders know about cybersecurity

People want to get things done, so they take shortcuts, engineer workarounds, and use weak passwords. On the other hand, they also want...

Report: HHS Secretary Azar mulls Brett Giroir as next FDA commissioner

Then-Texas Task Force on Infectious Disease Preparedness and Response Director Dr. Brett Giroir at an October 2014 press conference in Dallas President Donald Trump...

‘Locally grown’ insurance companies help fortify Washington state market

Although few states have finalized their 2020 health insurance rates yet, preliminary reports suggest that increases in premiums for plans sold on the...

Luma Health scores $16 million in Series B round

San Francisco-based patient communication company Luma Health announced Tuesday that it has raised $16 million from existing and new investors. The Series B funding...

Documents reveal conflict between VA and unelected Trump advisors

Mar-a-Lago on Palm Beach Island, Palm Beach, Florida, USA New documents obtained by government watchdog group Citizens for Responsibility and Ethics in Washington have lent...

SEC charges TherapeuticsMD with violating disclosure rules

The federal government has charged a pharmaceutical company that makes women’s health drugs with violating disclosure rules. The Securities and Exchange Commission said Tuesday...

FDA gives thumbs down to Sarepta’s next Duchenne’s muscular dystrophy drug

A new drug for Duchenne muscular dystrophy failed to win Food and Drug Administration approval Monday. Cambridge, Massachusetts-based Sarepta Therapeutics said that it had...

Ciitizen launches scorecard to rate providers on patient data access

The concern over healthcare data breaches and healthcare data privacy has added to the growing movement toward individual patient control over their own...

FDA approves AbbVie rheumatoid arthritis drug

The Food and Drug Administration has approved a new drug for rheumatoid arthritis made by AbbVie. The Chicago-based drugmaker said Friday that the FDA...

FDA approves first drug for blood disorder myelofibrosis since 2011

The Food and Drug Administration has approved the first new drug for a type of rare blood cancer in nearly a decade. The FDA...